Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
5.12
-0.03 (-0.58%)
At close: Apr 28, 2026, 4:00 PM EDT
5.19
+0.07 (1.37%)
After-hours: Apr 28, 2026, 5:07 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $27.60 million as of April 28, 2026. Its market cap has increased by 220.59% in one year.
Market Cap
27.60M
Enterprise Value
5.68M
1-Year Change
220.59%
Ranking
Category
Stock Price
$5.12
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $27.60M, an increase of 155.83%. That is a compound annual growth rate of 101.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 27.76M | 33.07% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 29.18M |
| Lisata Therapeutics | 28.99M |
| Outlook Therapeutics | 28.77M |
| Kyntra Bio | 28.53M |
| Tevogen Bio Holdings | 27.67M |
| Apollomics | 27.59M |
| NeuroSense Therapeutics | 27.50M |
| NanoViricides | 27.21M |